Brief: Aridis Pharmaceuticals Announces Q2 2022 Results
16/08/2022 23:17
Aug 16 (Reuters) - Aridis Pharmaceuticals Inc ARDS.O :
* ARIDIS PHARMACEUTICALS ANNOUNCES Q2 2022 FINANCIAL RESULTS
AND
BUSINESS UPDATE
* ARIDIS PHARMACEUTICALS INC - QTRLY TOTAL CASH, CASH
EQUIVALENTS
AND RESTRICTED CASH OF APPROXIMATELY $8.0 MILLION
* ARIDIS PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.45
Source text for Eikon: ID:nPn3DcQ5ka
Further company coverage: ARDS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aridis Pharmaceuticals
See all newsBrief: Aridis Pharmaceuticals Inc - On September 7 Nasdaq Announced That It Would Delist Common Stock Of Co
U.S. STOCKS ON THE MOVE-Pieris Pharma, Microsoft, Energy sector
U.S. STOCKS ON THE MOVE-Medtronic, Morgan Stanley, Bank of America
U.S. STOCKS ON THE MOVE-Teladoc Health, NVDIA, Chipotle
U.S. STOCKS ON THE MOVE-Pinterest, Sunrun, Tencent Music